Nestle In Development of Products for Treatment of Diabetes and Obesity

Mon, 27 Sep 2010
Nestle SA, the world’s biggest food company have unveiled a medical nutrition business for the development of foods for the treatment and prevention of diabetes, heart disease, obesity and Alzheimers .

Nestle stated that it is going to invest hundreds of millions of Swiss francs into the Nestle Institute of Health Sciences, in Lausanne, in the next ten years, whilst the new subsidiary becomes operational in January 2011.

In 2009 Nestle achieved sales of 108 billion Swiss francs or £64.5 billion.

The cost of care for those with chronic conditions is on the increase.

Nestle chairman Peter Brabeck-Letmathe stated: "The combination of health economics, changing demographics and advances in health science show that our existing healthcare systems, which focus on treating sick people, are not sustainable and need redesigning."

The food manufacturer is setting up this new division as regulators increasingly scrutinise the food industry’s health benefits promotion.

Link to this page

Copy and Paste the following HTML into your page.